Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Birgitte Bentz Damholt
Observed names:
B. Damholt,
Birgitte Damholt
Institution:
Novo Nordisk (Denmark)
Observed institutions:
Novo Nordisk (Denmark),
Institut Gustave Roussy,
Innate Pharma (France),
Hôpital Saint-Louis,
Institut Paoli-Calmettes
ORCID:
0000-0002-0036-8345
Observed ORCID:
0000-0002-0036-8345
OpenAlex ID:
A5000713530
Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice
2023
·
Yilmaz Emre Gencay
, Džiuginta Jasinskytė
, et al.
·
Nature Biotechnology
·
317
PDF
Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes
2006
·
O. Klein
, J. Lynge
, et al.
·
Diabetes Obesity and Metabolism
·
255
An Open‐Label, Parallel Group Study Investigating the Effects of Age and Gender on the Pharmacokinetics of the Once‐Daily Glucagon‐Like Peptide‐1 Analogue Liraglutide
2006
·
Birgitte Damholt
, Georg Golor
, et al.
·
The Journal of Clinical Pharmacology
·
88
Safety, recovery, and pharmacodynamics of CRISPR–Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study
2026
·
Anders Østergaard Petersen
, Birgitte Damholt
, et al.
·
The Lancet Microbe
·
17
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial
2021
·
Violetta Csákváry
, Nicola Ammer
, et al.
·
Hormone Research in Paediatrics
·
16
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects
2021
·
Hans Helleberg
, Mads Bjelke
, et al.
·
European Journal of Pharmaceutical Sciences
·
13
PDF
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
2021
·
Theodoros Papathanasiou
, Henrik Agersø
, et al.
·
Clinical Pharmacokinetics
·
13
PDF
Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials
2021
·
Birgitte Bentz Damholt
, Sarah Louise Dombernowsky
, et al.
·
Clinical Pharmacokinetics
·
8
PDF
A phase I study of the anti-natural killer inhibitory receptor (KIR) monoclonal antibody (1–7F9, IPH2101) in elderly patients with acute myeloid leukemia (AML)
2009
·
N. Vey
, J. Bourhis
, et al.
·
Journal of Clinical Oncology
·
7
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial
2024
·
Sarah Louise Dombernowsky
, Birgitte Bentz Damholt
, et al.
·
Clinical Pharmacokinetics
·
1
Pharmacokinetics and Pharmacodynamics of Macimorelin Acetate (AEZS-130) in Paediatric Patients With Suspected Growth Hormone Deficiency (GHD)
2021
·
Violetta Csákváry
, Agota Muzsnai
, et al.
·
Journal of the Endocrine Society
·
1
PDF
Metabolism of Somapacitan, a Long-Acting Growth Hormone Derivative, in Human Subjects
2019
·
Birgitte Bentz Damholt
, Mads Bjelke
, et al.
·
58th Annual ESPE Meeting (ESPE 2019)
Absorption and Excretion of Somapacitan, a Long-Acting Growth Hormone (GH) Derivative
2018
·
Michael Højby Rasmussen
, Birgitte Bentz Damholt
, et al.
·
57th Annual ESPE
Show more works
View as search
Works count:
13
Citation count:
736
H-index:
8
I10-index:
7
Year
Topic
Type